GailM.H., BrintonL.A., ByarD.P.Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst.1989; 81: 1879–1886.
2.
FisherB., CostantinoJ.P., RedmondC.K.Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst.1994; 86: 527–537.
3.
FisherB., DignamJ., BryantJ.Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst.1996; 88: 1529–1542.
4.
FisherB.Commentary on endometrial cancer deaths in tamoxifen-treated breast cancer patients. J Clin Oncol.1996; 14: 1027–1039.
